Infect Chemother.  2014 Mar;46(1):54-58. 10.3947/ic.2014.46.1.54.

Mycotic Abdominal Aortic Aneurysm Caused by Bacteroides Thetaiotaomicron and Acinetobacter Lwoffii: The First Case in Korea

• Kim MG
• Jeon JW
• Ryu IH
• Lee JJ
• Kim JS
• Choi JW
• Cho BS
• Yoon HJ

• KMID: 2170462
• DOI: http://doi.org/10.3947/ic.2014.46.1.54

Abstract

Mycotic aneurysms are uncommon, but are fatal without appropriate management. Previous reports have shown that anaerobes and gram-negative organisms are less common but more dangerous than other causative agents of mycotic aneurysm. We report the case of a 60-year-old man with poorly controlled diabetes mellitus and atherosclerosis in the aorta, and a 10-day of history of lower abdominal pain and fever. This man was diagnosed with an uncommon abdominal aorta mycotic aneurysm caused by Bacteroides thetaiotaomicron and Acinetobacter lwoffii. The aneurysm was successfully treated with antibiotics therapy and aorto-bi-external iliac artery bypass with debridement of the infected aortic wall. We present this case together with a review of the relevant literature.

Keyword

Aneurysm; Infected; Bacteroides thetaiotaomicron; Acinetobacter lwoffii

MeSH Terms

Abdominal Pain
Acinetobacter*
Aneurysm
Aneurysm, Infected
Anti-Bacterial Agents
Aorta
Aorta, Abdominal
Aortic Aneurysm, Abdominal*
Atherosclerosis
Bacteroides*
Debridement
Diabetes Mellitus
Fever
Humans
Iliac Artery
Korea*
Middle Aged
Anti-Bacterial Agents

Figure

• 

  Figure 1 (A, B) A 2.1-cm (diameter) saccular aneurysm (arrows) with periaortic fluid collection was visible in the abdominal aorta at the L3 level.

• 

  Figure 2 (A, B) Enhanced computed tomography (CT) showed an enlarged (diameter from 2.1 cm to 2.7 cm) aneurysm (arrows) in a state of impending rupture.

• 

  Figure 3 (A, B) Postoperative computed tomography (CT) showed the successfully inserted aorto-iliac graft (arrows) and no complications.

Reference

1. Lopes RJ, Almeida J, Dias PJ, Pinho P, Maciel MJ. Infectious thoracic aortitis: a literature review. Clin Cardiol. 2009; 32:488–490.

2. Gornik HL, Creager MA. Aortitis. Circulation. 2008; 117:3039–3051.

3. Malouf JF, Chandrasekaran K, Orszulak TA. Mycotic aneurysms of the thoracic aorta: a diagnostic challenge. Am J Med. 2003; 115:489–496.

4. Müller BT, Wegener OR, Grabitz K, Pillny M, Thomas L, Sandmann W. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg. 2001; 33:106–113.

5. Johnson JR, Ledgerwood AM, Lucas CE. Mycotic aneurysm. New concepts in therapy. Arch Surg. 1983; 118:577.

6. Maeda H, Umezawa H, Goshima M, et al. Primary infected abdominal aortic aneurysm: surgical procedures, early mortality rates, and a survey of the prevalence of infectious organisms over a 30-year period. Surg Today. 2011; 41:346.

7. Johansen K, Devin J. Mycotic aortic aneurysms: a reappraisal. Arch Surg. 1983; 118:583–588.

8. Gomes MN, Choyke PL. Infected aortic aneurysms: CT diagnosis. J Cardiovasc Surg (Torino). 1992; 33:684–689.

9. Lee HL, Liu KH, Yang YJ, Kan CD. Bacteroides fragilis aortic arch pseudoaneurysm: case report with review. J Cardiothorac Surg. 2008; 3:29.

10. Jarrett F, Darling RC, Mundth ED, Austen WG. Experience with infected aneurysms of the abdominal aorta. Arch Surg. 1975; 110:1281–1286.

11. Miragliotta G, Del Gaudio T, Tajani E, Mosca A. Bacteroides thetaiotaomicron in posthysterectomy infection. Anaerobe. 2006; 12:276–278.

12. Rathinavelu S, Zavros Y, Merchant JL. Acinetobacter lwoffii infection and gastritis. Microbes Infect. 2003; 5:651–657.

13. Weinstein MP. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol. 2003; 41:2275–2278.

14. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis. 1996; 23:Suppl 1. S97–S101.

15. Kan CD, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007; 46:906–912.